Pharmacoeconomics Status in Asia and an Emerging Hub in the Indo-Pak
Halima Sadia★, Hina Rehman2, Safila Naveed3★ Corresponding author
- 1Department of Pharmacy Practice, Faculty of Pharmacy, Jinnah University for Women, Nazimabad 5C, Karachi, PAKISTAN.
- 2Department of Pharmacy Practice, Faculty of Pharmacy, Jinnah Sindh Medical University, Rafiqui Shaheed Road, Karachi, PAKISTAN.
- 3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jinnah University for Women, Nazimabad 5C, Karachi, PAKISTAN.
Received: 25-10-2018; Revised: 24-01-2019; Accepted: 25-04-2019.
Volume 53, Issue 3 · pp. 376–381 · PUBLISHED 2019 · DOI: 10.5530/ijper.53.3.71
ABSTRACT
Objective: A review has been carried out to understand pharmacoeconomics and its development in the Asian region. Findings: Pharmacoeconomics is a subset of health economics which applies the methodologies and principles of health economics in clinical decision making. Currently, a number of countries around the globe have implemented pharmacoeconomics in their health care systems. However, the development of pharmacoeconomics in the Asia is very debatable. With countries like South Korea, Japan, China and Thailand where health economics is not only being implemented but is also progressing very rapidly, the southern part of Asia specifically India and Pakistan are far behind. Summary: Pharmacoecomics is in very infancy in the South Asia especially in India and Pakistan. It is the need of the hour to improve the practice and development of new pharmacoeconomics guidelines to meet up the standards of the remaining world.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sadia, H., Rehman, H., & Naveed, S. (2019). Pharmacoeconomics Status in Asia and an Emerging Hub in the Indo-Pak. Indian Journal of Pharmaceutical Education and Research, 53(3), 376–381. https://doi.org/10.5530/ijper.53.3.71